ANI PHARMACEUTICALS I
59.99
16-May-25 16:45:00
15 minutes delayed
Stocks
+0.46
+0.77%
Today's range
58.99 - 60.60
ISIN
N/A
Source
NASDAQ
-
31 Jul 2024 07:00:00 By Nasdaq GlobeNewswire
-
ANI Pharmaceuticals Announces the FDA Approval and Launch of L-Glutamine Oral Powder
15 Jul 2024 07:00:00 By Nasdaq GlobeNewswire
-
ANI Pharmaceuticals Announces the FDA Approval and Launch of Naproxen Delayed-Release Tablets, USP
02 Jul 2024 07:00:00 By Nasdaq GlobeNewswire
-
25 Jun 2024 07:00:02 By Nasdaq GlobeNewswire
-
ANI Pharmaceuticals to Further Expand Rare Disease Business through Acquisition of Alimera Sciences
24 Jun 2024 06:50:44 By Nasdaq GlobeNewswire
-
ANI Pharmaceuticals to Present at the 2024 Jefferies Global Healthcare Conference
29 May 2024 16:30:00 By Nasdaq GlobeNewswire
-
ANI Pharmaceuticals Announces the Launch of Kionex® Suspension
20 May 2024 06:50:00 By Nasdaq GlobeNewswire
-
ANI Pharmaceuticals Reports Record First Quarter 2024 Financial Results and Reiterates 2024 Guidance
10 May 2024 06:50:00 By Nasdaq GlobeNewswire
-
ANI Pharmaceuticals to Participate at Two Upcoming Healthcare Conferences
01 May 2024 16:30:00 By Nasdaq GlobeNewswire
-
ANI Pharmaceuticals to Discuss First Quarter 2024 Financial Results on May 10, 2024, at 8:30 a.m. ET
18 Apr 2024 16:05:00 By Nasdaq GlobeNewswire
-
ANI Pharmaceuticals Announces the Launch of Baclofen Oral Suspension
09 Apr 2024 06:50:00 By Nasdaq GlobeNewswire
-
ANI Pharmaceuticals Recognizes Sarcoidosis Awareness Month and Patients Living with Sarcoidosis
04 Apr 2024 06:50:00 By Nasdaq GlobeNewswire
-
ANI Pharmaceuticals to Participate at the Piper Sandler Spring Biopharma Symposium
03 Apr 2024 06:50:00 By Nasdaq GlobeNewswire
-
ANI Pharmaceuticals Announces the Launch of Levofloxacin Oral Solution, USP
27 Mar 2024 06:50:00 By Nasdaq GlobeNewswire
-
29 Feb 2024 06:50:01 By Nasdaq GlobeNewswire
-
ANI Pharmaceuticals to Present at the Leerink Partners Global Biopharma Conference
20 Feb 2024 06:50:00 By Nasdaq GlobeNewswire
-
07 Feb 2024 06:50:00 By Nasdaq GlobeNewswire
-
29 Jan 2024 06:50:00 By Nasdaq GlobeNewswire
-
ANI Pharmaceuticals Announces the Launch of Pentoxifylline Extended-Release Tablets, USP
23 Jan 2024 06:50:00 By Nasdaq GlobeNewswire
-
ANI Pharmaceuticals Announces the FDA Approval and Launch of Indomethacin Oral Suspension, USP
16 Jan 2024 06:50:00 By Nasdaq GlobeNewswire